Add to My Stocks
$17.58 $0.01 (0.06%) APNHY stock closing price Aug 16, 2018 (Closing)

For analyzing any company like ASPEN PHARMACR from an investment perspective, its important to check the cash flow statement. While its important to look at the ASPEN PHARMACR debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as ASPEN PHARMACR revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. This statement can tell if a company is running out of money while still being profitable and is useful in ASPEN PHARMACR stock analysis. ASPEN PHARMACR had a positive net income cash flow of $448.35M till this quarter of 2018 Q2. This report is very useful in measuring the short term viability of a company. ASPEN PHARMACR has a negative cash and cash equivalents change of $-7.35M.

View and download details of ASPEN PHARMACR cash flows for latest & last 40 quarters
show more
Fiscal year is Jul - Jun2018 Q22017 Q42017 Q22016 Q4
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow-95.55M-83.28M
Net Increase (Decrease) in Assets Liabilities-110.25M-66.14M-50.26M-235.96M
Cash From (used in) Discontinued Operations----
Other Adjustments Net-117.6M-161.7M-114.88M-249.84M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-58.8M-110.25M-50.26M-117.98M
Acquisition Disposition of Subsidiaires--698.25M-430.8M-48.58M
Increase (Decrease) in Investments----
Other Cash Inflow (Outflow) from Investment Activities-536.55M-51.45M-78.98M242.9M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares----6.94M
Issuance (Repayment) of Debt Securities470.4M455.7M430.8M-138.8M
Increase (Decrease) in Bank & Other Borrowings----
Payment of Dividends & Other Cash Distributions-95.55M-88.2M-78.98M-69.4M
Other Cash from (used by) Financing Activities----
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-7.35M-36.75M-50.26M-13.88M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year478.86M---
Cash & Equivalents at Year End521.85M529.2M538.5M548.26M
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The ASPEN PHARMACR stock price history and ASPEN PHARMACR stock comparison chart inevitably reflect its cash flow situation.

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that ASPEN PHARMACR is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - ASPEN PHARMACR stock price movement.
  • ASPEN PHARMACR increased its cash from operating activities to $220.5M till 2018 Q2. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-595.35M for APNHY till last quarter 2018 Q2 report.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $374.85M for ASPEN PHARMACR. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For ASPEN PHARMACR Cash Flow